China NGS-based RNA-seq Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.

    Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.

    This report elaborates on the current development of the NGS-based RNA-seq industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pacific Biosciences Of California

    • Qaigen

    • Macrogen

    • Eurofins Scientific

    • Thermo Fisher Scientific

    • Perkinelmer

    • Gatc Biotech

    • F Hoffmann-La Roche

    • Agilent Technologies

    By Type:

    • SMRT

    • SBS

    By Application:

    • Small RNA

    • Transcriptome Epigenetics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China NGS-based RNA-seq Market Overview 2018-2029

    • 1.1 China NGS-based RNA-seq Industry Development Overview

    • 1.2 China NGS-based RNA-seq Industry Development History

    • 1.3 China NGS-based RNA-seq Industry Market Size (2018-2029)

    • 1.4 China NGS-based RNA-seq Market Analysis by Type from Production Side

      • 1.4.1 China NGS-based RNA-seq Production Volume, Production Value and Growth Rate of SMRT (2018-2029)

      • 1.4.2 China NGS-based RNA-seq Production Volume, Production Value and Growth Rate of SBS (2018-2029)

    • 1.5 China NGS-based RNA-seq Market Analysis by Application from Consumption End

      • 1.5.1 China NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate of Small RNA (2018-2029)

      • 1.5.2 China NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate of Transcriptome Epigenetics (2018-2029)

    • 1.6 China NGS-based RNA-seq Market Analysis by Region

      • 1.6.1 North China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

    Chapter 2 China NGS-based RNA-seq Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on NGS-based RNA-seq Market Status and Competition at home and abroad in 2023

      • 2.2.2 China NGS-based RNA-seq Market Status and Competition Analysis in 2023

      • 2.2.3 China NGS-based RNA-seq Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China NGS-based RNA-seq Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on NGS-based RNA-seq Industry Development

    Chapter 3 NGS-based RNA-seqIndustry Chain Analysis

    • 3.1 NGS-based RNA-seq Industry Chain

    • 3.2 NGS-based RNA-seq Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the NGS-based RNA-seq Market

    • 3.3 NGS-based RNA-seq Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the NGS-based RNA-seq Market

    Chapter 4 China NGS-based RNA-seq Market, by Type

    • 4.1 China NGS-based RNA-seq Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China NGS-based RNA-seq Total Production Volume and Growth Rate from Production Side

    • 4.5 China NGS-based RNA-seq Production Volume and Growth Rate, by Type

      • 4.5.1 China NGS-based RNA-seq Production Volume and Growth Rate of SMRT

      • 4.5.2 China NGS-based RNA-seq Production Volume and Growth Rate of SBS

    Chapter 5 China NGS-based RNA-seq Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China NGS-based RNA-seq Total Market Size and Growth Rate from Consumption End

    • 5.5 China NGS-based RNA-seq Market Size and Growth Rate, by Application

      • 5.5.1 China NGS-based RNA-seq Market Size and Growth Rate of Small RNA

      • 5.5.2 China NGS-based RNA-seq Market Size and Growth Rate of Transcriptome Epigenetics

    Chapter 6 China NGS-based RNA-seq Market, by Region

    • 6.1 China NGS-based RNA-seq Production Volume and Production Value, by Region

    • 6.2 China NGS-based RNA-seq Sales Volume and Sales Value, by Region

    Chapter 7 North China NGS-based RNA-seq Market Analysis

    • 7.1 North China NGS-based RNA-seq Market, by Type

    • 7.2 North China NGS-based RNA-seq Market, by Application

    Chapter 8 Central China NGS-based RNA-seq Market Analysis

    • 8.1 Central China NGS-based RNA-seq Market, by Type

    • 8.2 Central China NGS-based RNA-seq Market, by Application

    Chapter 9 South China NGS-based RNA-seq Market Analysis

    • 9.1 South China NGS-based RNA-seq Market, by Type

    • 9.2 South China NGS-based RNA-seq Market, by Application

    Chapter 10 East China NGS-based RNA-seq Market Analysis

    • 10.1 East China NGS-based RNA-seq Market, by Type

    • 10.2 East China NGS-based RNA-seq Market, by Application

    Chapter 11 Northeast China NGS-based RNA-seq Market Analysis

    • 11.1 Northeast China NGS-based RNA-seq Market, by Type

    • 11.2 Northeast China NGS-based RNA-seq Market, by Application

    Chapter 12 Southwest China NGS-based RNA-seq Market Analysis

    • 12.1 Southwest China NGS-based RNA-seq Market, by Type

    • 12.2 Southwest China NGS-based RNA-seq Market, by Application

    Chapter 13 Northwest China NGS-based RNA-seq Market Analysis

    • 13.1 Northwest China NGS-based RNA-seq Market, by Type

    • 13.2 Northwest China NGS-based RNA-seq Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pacific Biosciences Of California

        • 14.1.1 Pacific Biosciences Of California Company Profile

        • 14.1.2 Pacific Biosciences Of California NGS-based RNA-seq Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Qaigen

        • 14.2.1 Qaigen Company Profile

        • 14.2.2 Qaigen NGS-based RNA-seq Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Macrogen

        • 14.3.1 Macrogen Company Profile

        • 14.3.2 Macrogen NGS-based RNA-seq Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eurofins Scientific

        • 14.4.1 Eurofins Scientific Company Profile

        • 14.4.2 Eurofins Scientific NGS-based RNA-seq Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Thermo Fisher Scientific

        • 14.5.1 Thermo Fisher Scientific Company Profile

        • 14.5.2 Thermo Fisher Scientific NGS-based RNA-seq Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Perkinelmer

        • 14.6.1 Perkinelmer Company Profile

        • 14.6.2 Perkinelmer NGS-based RNA-seq Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Gatc Biotech

        • 14.7.1 Gatc Biotech Company Profile

        • 14.7.2 Gatc Biotech NGS-based RNA-seq Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 F Hoffmann-La Roche

        • 14.8.1 F Hoffmann-La Roche Company Profile

        • 14.8.2 F Hoffmann-La Roche NGS-based RNA-seq Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Agilent Technologies

        • 14.9.1 Agilent Technologies Company Profile

        • 14.9.2 Agilent Technologies NGS-based RNA-seq Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 NGS-based RNA-seq Industry Research Conclusions

    • 15.2 NGS-based RNA-seq Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China NGS-based RNA-seq Industry Market Size (2018-2029)

    • Figure China NGS-based RNA-seq Production Volume, Production Value and Growth Rate of SMRT (2018-2029)

    • Figure China NGS-based RNA-seq Production Volume, Production Value and Growth Rate of SBS (2018-2029)

    • Figure China NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate of Small RNA (2018-2029)

    • Figure China NGS-based RNA-seq Sales Volume, Sales Value and Growth Rate of Transcriptome Epigenetics (2018-2029)

    • Figure North China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

    • Figure Central China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

    • Figure South China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

    • Figure East China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

    • Figure Northeast China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

    • Figure Southwest China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

    • Figure Northwest China NGS-based RNA-seq Market Size and Growth Rate from 2018-2029

    • Figure NGS-based RNA-seq Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China NGS-based RNA-seq Market Share by Type in 2018

    • Figure China NGS-based RNA-seq Market Share by Type in 2023

    • Figure China NGS-based RNA-seq Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China NGS-based RNA-seq Production Volume and Growth Rate of SMRT (2018-2023)

    • Figure China NGS-based RNA-seq Production Volume and Growth Rate of SBS (2018-2023)

    • Figure China NGS-based RNA-seq Market Share by Application in 2018

    • Figure China NGS-based RNA-seq Market Share by Application in 2023

    • Figure China NGS-based RNA-seq Total Market Size and Growth Rate from Consumption End

    • Figure China NGS-based RNA-seq Market Size and Growth Rate of Small RNA (2018-2023)

    • Figure China NGS-based RNA-seq Market Size and Growth Rate of Transcriptome Epigenetics (2018-2023)

    • Table China NGS-based RNA-seq Production Volume by Region (2018-2023)

    • Table China NGS-based RNA-seq Production Volume Share by Region (2018-2023)

    • Figure China NGS-based RNA-seq Production Volume Share by Region (2018-2023)

    • Table China NGS-based RNA-seq Production Value by Region (2018-2023)

    • Table China NGS-based RNA-seq Production Value Share by Region (2018-2023)

    • Figure China NGS-based RNA-seq Production Value Share by Region (2018-2023)

    • Table China NGS-based RNA-seq Sales Volume by Region (2018-2023)

    • Table China NGS-based RNA-seq Sales Volume Share by Region (2018-2023)

    • Figure China NGS-based RNA-seq Sales Volume Share by Region (2018-2023)

    • Table China NGS-based RNA-seq Sales Value by Region (2018-2023)

    • Table China NGS-based RNA-seq Sales Value Share by Region (2018-2023)

    • Figure China NGS-based RNA-seq Sales Value Share by Region (2018-2023)

    • Table North China NGS-based RNA-seq Production Volume by Type (2018-2023)

    • Table North China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Figure North China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Table North China NGS-based RNA-seq Sales Volume by Application (2018-2023)

    • Table North China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Figure North China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Table Central China NGS-based RNA-seq Production Volume by Type (2018-2023)

    • Table Central China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Figure Central China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Table Central China NGS-based RNA-seq Sales Volume by Application (2018-2023)

    • Table Central China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Figure Central China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Table South China NGS-based RNA-seq Production Volume by Type (2018-2023)

    • Table South China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Figure South China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Table South China NGS-based RNA-seq Sales Volume by Application (2018-2023)

    • Table South China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Figure South China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Table East China NGS-based RNA-seq Production Volume by Type (2018-2023)

    • Table East China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Figure East China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Table East China NGS-based RNA-seq Sales Volume by Application (2018-2023)

    • Table East China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Figure East China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Table Northeast China NGS-based RNA-seq Production Volume by Type (2018-2023)

    • Table Northeast China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Figure Northeast China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Table Northeast China NGS-based RNA-seq Sales Volume by Application (2018-2023)

    • Table Northeast China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Figure Northeast China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Table Southwest China NGS-based RNA-seq Production Volume by Type (2018-2023)

    • Table Southwest China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Figure Southwest China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Table Southwest China NGS-based RNA-seq Sales Volume by Application (2018-2023)

    • Table Southwest China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Figure Southwest China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Table Northwest China NGS-based RNA-seq Production Volume by Type (2018-2023)

    • Table Northwest China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Figure Northwest China NGS-based RNA-seq Production Volume Share by Type (2018-2023)

    • Table Northwest China NGS-based RNA-seq Sales Volume by Application (2018-2023)

    • Table Northwest China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Figure Northwest China NGS-based RNA-seq Sales Volume Share by Application (2018-2023)

    • Table Pacific Biosciences Of California Company Profile

    • Table Pacific Biosciences Of California NGS-based RNA-seq Revenue, Price and Gross (2018-2023)

    • Table Qaigen Company Profile

    • Table Qaigen NGS-based RNA-seq Revenue, Price and Gross (2018-2023)

    • Table Macrogen Company Profile

    • Table Macrogen NGS-based RNA-seq Revenue, Price and Gross (2018-2023)

    • Table Eurofins Scientific Company Profile

    • Table Eurofins Scientific NGS-based RNA-seq Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Company Profile

    • Table Thermo Fisher Scientific NGS-based RNA-seq Revenue, Price and Gross (2018-2023)

    • Table Perkinelmer Company Profile

    • Table Perkinelmer NGS-based RNA-seq Revenue, Price and Gross (2018-2023)

    • Table Gatc Biotech Company Profile

    • Table Gatc Biotech NGS-based RNA-seq Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Company Profile

    • Table F Hoffmann-La Roche NGS-based RNA-seq Revenue, Price and Gross (2018-2023)

    • Table Agilent Technologies Company Profile

    • Table Agilent Technologies NGS-based RNA-seq Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.